McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
BIIB holding history
Biogen Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIIB overviewAll 13F holders of BIIBFull Q1 2026 holdings
- Shares (Q1 2026)
- 43
- Value
- $7.82K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 43 | $7.82K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 43 | $7.51K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 43 | $5.98K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 43 | $5.36K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 43 | $5.84K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 43 | $6.53K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 43 | $8.27K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 43 | $9.89K | <0.1% | −6−12.2% | Reduced | Holders |
| Q1 2024 | 49 | $10.6K | <0.1% | −1−2.0% | Reduced | Holders |
| Q4 2023 | 50 | $12.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 50 | $12.9K | <0.1% | −6−10.7% | Reduced | Holders |
| Q2 2023 | 56 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 56 | $15.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 56 | $15.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 56 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 56 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 56 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 56 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 56 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 56 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 56 | $16.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.